- Home
- KYNB vs EKSO Comparison
KYNB vs EKSO Comparison
Compare KYNB & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KYNB | EKSO |
|---|---|---|
| Founded | 1993 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.9M | 37.9M |
| IPO Year | N/A | 2012 |
Fundamental Metrics
Financial Performance| Metric | KYNB | EKSO |
|---|---|---|
| Price | $7.16 | $11.38 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.50 |
| AVG Volume (30 Days) | 19.2K | ★ 58.7K |
| Earning Date | 05-11-2026 | 04-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 41.76 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $81.23 |
| Revenue Next Year | N/A | $7.29 |
| P/E Ratio | $0.15 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.32 | $0.23 |
| 52 Week High | $9.58 | $13.50 |
Technical Indicators
Market Signals| Indicator | KYNB | EKSO |
|---|---|---|
| Relative Strength Index (RSI) | 50.47 | 60.12 |
| Support Level | $7.11 | $9.18 |
| Resistance Level | $7.52 | $13.16 |
| Average True Range (ATR) | 0.28 | 0.97 |
| MACD | 0.05 | 0.19 |
| Stochastic Oscillator | 66.09 | 94.07 |
Price Performance
Historical ComparisonAbout KYNB Kyntra Bio Inc. Common Stock
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.